Stock Events

Stock Events

Guardant Health 

$155.68
153
-$5.36-3.33% 17:09 Today

Statistics

Day High
159.33
Day Low
155.35
52W High
176.58
52W Low
53.4
Volume
28,076
Avg. Volume
-
Mkt Cap
20.89B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-1
-0.91
-0.83
-0.74
Expected EPS
-0.754436
Actual EPS
N/A

Financials

-42.39%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
982.02MRevenue
-416.28MNet Income

Analyst Ratings

192.06Average Price Target
The highest estimate is 215.00.
From 17 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GH. It's not an investment recommendation.
NVIDIA
35
NVDA
Alphabet
32
GOOGL
Amazon
28
AMZN
AMD
27
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides genomic sequencing solutions and competes directly in the precision medicine space, offering technologies that overlap with Guardant Health's cancer detection and treatment monitoring services.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the genomic and molecular diagnostics space with Guardant Health.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers sequencing systems that compete in the broader market of genomic analysis, including applications in cancer research and diagnostics.
Bionano Genomics
BNGO
Mkt Cap13.78M
Bionano Genomics provides tools for genomic analysis, including structural variant detection that can be applied in cancer research, competing in the genomics space.
Myriad Genetics
MYGN
Mkt Cap302.25M
Myriad Genetics offers genetic testing and precision medicine solutions, including for cancer, competing with Guardant Health in the personalized healthcare market.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen provides sample and assay technologies for molecular diagnostics, including cancer, competing in the field of precision medicine and diagnostics.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of solutions for genetic analysis and diagnostics, including cancer, competing with Guardant Health in the life sciences and healthcare sectors.

About

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Show more...
CEO
Helmy Eltoukhy
Employees
2506
Country
United States
ISIN
US40131M1099
WKN
000A2N5RY

Listings

MI
IT
1GH.MI
STU
DE
5GH.STU
MU
DE
5GH.MU
F
DE
5GH.F

0 Comments

Share your thoughts

FAQ

What is Guardant Health stock price today?▼
The current price of GH is $155.68 USD — it has decreased by -3.33% in the past 24 hours. Watch Guardant Health stock price performance more closely on the chart.
What is Guardant Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Guardant Health stocks are traded under the ticker GH.
Is Guardant Health stock price growing?▼
GH stock has fallen by -3.75% compared to the previous week, the month change is a -2.72% fall, over the last year Guardant Health has showed a +153.32% increase.
What is Guardant Health market cap?▼
Today Guardant Health has the market capitalization of 20.89B
When is the next Guardant Health earnings date?▼
Guardant Health is going to release the next earnings report on October 29, 2026.
What were Guardant Health earnings last quarter?▼
GH earnings for the last quarter are -0.9 USD per share, whereas the estimation was -0.76 USD resulting in a -18.14% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Guardant Health revenue for the last year?▼
Guardant Health revenue for the last year amounts to 982.02M USD.
What is Guardant Health net income for the last year?▼
GH net income for the last year is -416.28M USD.
How many employees does Guardant Health have?▼
As of September 04, 2026, the company has 2,506 employees.
In which sector is Guardant Health located?▼
Guardant Health operates in the Health & Wellness sector.
When did Guardant Health complete a stock split?▼
Guardant Health has not had any recent stock splits.
Where is Guardant Health headquartered?▼
Guardant Health is headquartered in PALO ALTO, United States.